Iranian Journal of Radiology

Published by: Kowsar

Rate of Malignancy in Exophytic Thyroid Nodules

Fatma Dilek Dellal 1 , * , Husniye Baser 1 , Dilek Arpaci 2 , Abbas Ali Tam 3 , Didem Ozdemir 3 , Aydan Kilicarslan 4 , Ersin Gurkan Dumlu 5 , Reyhan Ersoy 3 and Bekir Cakir 3
Authors Information
1 Department of Endocrinology and Metabolism, Ataturk Training and Research Hospital, Ankara, Turkey
2 Department of Endocrinology and Metabolism, Bulent Ecevit University, Zonguldak, Turkey
3 Department of Endocrinology and Metabolism, Faculty of Medicine, Yildirim Beyazit University, Ankara, Turkey
4 Department of Pathology, Faculty of Medicine, Yildirim Beyazit University, Ankara, Turkey
5 Department of Surgery, Faculty of Medicine, Yildirim Beyazit University, Ankara, Turkey
Article information
  • Iranian Journal of Radiology: April 2017, 14 (2); e41141
  • Published Online: February 25, 2017
  • Article Type: Research Article
  • Received: August 3, 2016
  • Revised: November 28, 2016
  • Accepted: January 25, 2017
  • DOI: 10.5812/iranjradiol.41141

To Cite: Dellal F D, Baser H, Arpaci D, Tam A A, Ozdemir D, et al. Rate of Malignancy in Exophytic Thyroid Nodules, Iran J Radiol. 2017 ; 14(2):e41141. doi: 10.5812/iranjradiol.41141.

Abstract
Copyright © 2017, Tehran University of Medical Sciences and Iranian Society of Radiology. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Footnotes
References
  • 1. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016; 26(1): 1-133[DOI][PubMed]
  • 2. Terzioglu T, Tezelman S, Onaran Y, Tanakol R. Concurrent hyperthyroidism and thyroid carcinoma. Br J Surg. 1993; 80(10): 1301-2[PubMed]
  • 3. Baskin Sr HJ, Duick DS, Levine RA. Thyroid ultrasound and ultrasound-guided FNA. 2012;
  • 4. Keles E, Ozkara S, Karlidag T, Ozercan IH. Thyroid tissue connected to normally located thyroid gland: ectopic or exophytic? Case Rep Otolaryngol. 2012; 2012: 681823[DOI][PubMed]
  • 5. Kim DW, Jung SJ, Baek HJ. Computed tomography features of benign and malignant solid thyroid nodules. Acta Radiol. 2015; 56(10): 1196-202[DOI][PubMed]
  • 6. Chaudhary V, Bano S. Thyroid ultrasound. Indian J Endocrinol Metab. 2013; 17(2): 219-27[DOI][PubMed]
  • 7. Yamashiro I, Saito O, Chammas MC, Cerri GG. Achados ultra-sonográficos na tireoidite. Radiologia Brasileira. 2007; 40(2): 75-9[DOI]
  • 8. Cibas ES, Ali SZ. The Bethesda System for Reporting Thyroid Cytopathology. Thyroid. 2009; 19(11): 1159-65[DOI][PubMed]
  • 9. Kratky J, Vitkova H, Bartakova J, Telicka Z, Antosova M, Limanova Z, et al. Thyroid nodules: pathophysiological insight on oncogenesis and novel diagnostic techniques. Physiol Res. 2014; 63 Suppl 2-75[PubMed]
  • 10. Gul K, Ersoy R, Dirikoc A, Korukluoglu B, Ersoy PE, Aydin R, et al. Ultrasonographic evaluation of thyroid nodules: comparison of ultrasonographic, cytological, and histopathological findings. Endocrine. 2009; 36(3): 464-72[DOI][PubMed]
  • 11. Salmaslioglu A, Erbil Y, Dural C, Issever H, Kapran Y, Ozarmagan S, et al. Predictive value of sonographic features in preoperative evaluation of malignant thyroid nodules in a multinodular goiter. World J Surg. 2008; 32(9): 1948-54[DOI][PubMed]
  • 12. Kwak JY, Han KH, Yoon JH, Moon HJ, Son EJ, Park SH, et al. Thyroid imaging reporting and data system for US features of nodules: a step in establishing better stratification of cancer risk. Radiology. 2011; 260(3): 892-9[DOI][PubMed]
  • 13. Henrichsen TL, Reading CC, Charboneau JW, Donovan DJ, Sebo TJ, Hay ID. Cystic change in thyroid carcinoma: Prevalence and estimated volume in 360 carcinomas. J Clin Ultrasound. 2010; 38(7): 361-6[DOI][PubMed]
  • 14. Frates MC, Benson CB, Charboneau JW, Cibas ES, Clark OH, Coleman BG, et al. Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement. Radiology. 2005; 237(3): 794-800[DOI][PubMed]
  • 15. Gkountouvas A, Thomas D, Tertipi A, Chrysanthou K, Kaldrimidis P. Exophytic and ulcerated local recurrence of papillary thyroid carcinoma with spectacular response to external beam radiotherapy. Thyroid. 2008; 18(9): 1015-6[DOI][PubMed]
  • 16. Spencer CA. Clinical review: Clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC). J Clin Endocrinol Metab. 2011; 96(12): 3615-27[DOI][PubMed]
  • 17. Vasileiadis I, Boutzios G, Charitoudis G, Koukoulioti E, Karatzas T. Thyroglobulin antibodies could be a potential predictive marker for papillary thyroid carcinoma. Ann Surg Oncol. 2014; 21(8): 2725-32[DOI][PubMed]
  • 18. Qin J, Yu Z, Guan H, Shi L, Liu Y, Zhao N, et al. High Thyroglobulin Antibody Levels Increase the Risk of Differentiated Thyroid Carcinoma. Dis Markers. 2015; 2015: 648670[DOI][PubMed]
  • 19. Paparodis R, Imam S, Todorova-Koteva K, Staii A, Jaume JC. Hashimoto's thyroiditis pathology and risk for thyroid cancer. Thyroid. 2014; 24(7): 1107-14[DOI][PubMed]
  • 20. Caballero Y, Lopez-Tomassetti EM, Favre J, Santana JR, Cabrera JJ, Hernandez JR. The value of thyroperoxidase as a prognostic factor for differentiated thyroid cancer -- a long-term follow-up study. Thyroid Res. 2015; 8: 12[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments